Jazz Pharmaceuticals plc 4

Renee D. Gala, President & CEO of Jazz Pharmaceuticals plc, had 4,835 ordinary shares withheld to cover taxes on RSU vesting, leaving her with 147,361 shares owned directly.

On June 30, 2026, Jazz Pharmaceuticals plc President & CEO Renee D. Gala had 4,835 ordinary shares withheld by the company at an implied price of $237.72 per share (approximately $1.15 million in value) to cover tax obligations arising from the vesting of previously granted restricted stock units, a non-discretionary, compensation-related transaction. Following this withholding, she beneficially owned 147,361 ordinary shares directly, representing a substantial continuing equity stake in the company.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

sec

Accession

0001607737-26-000011

Alert Tier

5